Difluprednate for the prevention of ocular inflammation postsurgery: an update

Eric D DonnenfeldOphthalmic Consultants of Long Island, Rockville Centre, NY, USAPurpose: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%.Methods: A comprehensive search of recent published literature including difluprednate was p...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Donnenfeld ED
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Ophthalmology RE1-994
Acceso en línea:	https://doaj.org/article/9c1dd1b86ea2459cb5eb4d312bda50c8
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:9c1dd1b86ea2459cb5eb4d312bda50c8
record_format	dspace
spelling	oai:doaj.org-article:9c1dd1b86ea2459cb5eb4d312bda50c82021-12-02T06:18:02ZDifluprednate for the prevention of ocular inflammation postsurgery: an update1177-54671177-5483https://doaj.org/article/9c1dd1b86ea2459cb5eb4d312bda50c82011-06-01T00:00:00Zhttp://www.dovepress.com/difluprednate-for-the-prevention-of-ocular-inflammation-postsurgery-an-a7650https://doaj.org/toc/1177-5467https://doaj.org/toc/1177-5483Eric D DonnenfeldOphthalmic Consultants of Long Island, Rockville Centre, NY, USAPurpose: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%.Methods: A comprehensive search of recent published literature including difluprednate was performed. Clinical studies relevant to the characteristics and clinical efficacy of difluprednate in controlling postoperative inflammation were included, and a synopsis of each study was developed.Results: Several recent publications were identified in which difluprednate was shown to be efficacious in the treatment of postoperative inflammation in different clinical settings, including a novel perioperative regimen. Additional literature retrieved from this search included data on the relative potency of difluprednate, potential utility in the posterior segment, as well as the advantages of the emulsion formulation.Conclusion: Difluprednate has been studied extensively and shown in recent literature to be a safe and effective topical anti-inflammatory drug. The proven strength and unique formulation of difluprednate, along with its potent efficacy in treating and preventing inflammation, provides clinicians with a beneficial treatment option.Keywords: corticosteroids, anti-inflammatory, dose uniformity, relative potencyDonnenfeld EDDove Medical PressarticleOphthalmologyRE1-994ENClinical Ophthalmology, Vol 2011, Iss default, Pp 811-816 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Ophthalmology RE1-994
spellingShingle	Ophthalmology RE1-994 Donnenfeld ED Difluprednate for the prevention of ocular inflammation postsurgery: an update
description	Eric D DonnenfeldOphthalmic Consultants of Long Island, Rockville Centre, NY, USAPurpose: To review the most recent published data regarding the novel potent steroid, difluprednate ophthalmic emulsion, 0.05%.Methods: A comprehensive search of recent published literature including difluprednate was performed. Clinical studies relevant to the characteristics and clinical efficacy of difluprednate in controlling postoperative inflammation were included, and a synopsis of each study was developed.Results: Several recent publications were identified in which difluprednate was shown to be efficacious in the treatment of postoperative inflammation in different clinical settings, including a novel perioperative regimen. Additional literature retrieved from this search included data on the relative potency of difluprednate, potential utility in the posterior segment, as well as the advantages of the emulsion formulation.Conclusion: Difluprednate has been studied extensively and shown in recent literature to be a safe and effective topical anti-inflammatory drug. The proven strength and unique formulation of difluprednate, along with its potent efficacy in treating and preventing inflammation, provides clinicians with a beneficial treatment option.Keywords: corticosteroids, anti-inflammatory, dose uniformity, relative potency
format	article
author	Donnenfeld ED
author_facet	Donnenfeld ED
author_sort	Donnenfeld ED
title	Difluprednate for the prevention of ocular inflammation postsurgery: an update
title_short	Difluprednate for the prevention of ocular inflammation postsurgery: an update
title_full	Difluprednate for the prevention of ocular inflammation postsurgery: an update
title_fullStr	Difluprednate for the prevention of ocular inflammation postsurgery: an update
title_full_unstemmed	Difluprednate for the prevention of ocular inflammation postsurgery: an update
title_sort	difluprednate for the prevention of ocular inflammation postsurgery: an update
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/9c1dd1b86ea2459cb5eb4d312bda50c8
work_keys_str_mv	AT donnenfelded difluprednateforthepreventionofocularinflammationpostsurgeryanupdate
_version_	1718400004483186688

Difluprednate for the prevention of ocular inflammation postsurgery: an update

Ejemplares similares